ATE163133T1 - Pharmazeutische zusammensetzung mit ortspezifischen verabreichung - Google Patents

Pharmazeutische zusammensetzung mit ortspezifischen verabreichung

Info

Publication number
ATE163133T1
ATE163133T1 AT93908149T AT93908149T ATE163133T1 AT E163133 T1 ATE163133 T1 AT E163133T1 AT 93908149 T AT93908149 T AT 93908149T AT 93908149 T AT93908149 T AT 93908149T AT E163133 T1 ATE163133 T1 AT E163133T1
Authority
AT
Austria
Prior art keywords
pct
site
pharmaceutical composition
spacer
sec
Prior art date
Application number
AT93908149T
Other languages
English (en)
Inventor
Erik Johannes Francis Franssen
Frits Moolenaar
Dirk Klaas Fokke Meijer
Zeeuw Dick De
Original Assignee
Univ Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Groningen filed Critical Univ Groningen
Application granted granted Critical
Publication of ATE163133T1 publication Critical patent/ATE163133T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT93908149T 1992-03-13 1993-03-15 Pharmazeutische zusammensetzung mit ortspezifischen verabreichung ATE163133T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9200481A NL9200481A (nl) 1992-03-13 1992-03-13 Farmaceutisch preparaat met plaatsgerichte afgifte.

Publications (1)

Publication Number Publication Date
ATE163133T1 true ATE163133T1 (de) 1998-02-15

Family

ID=19860559

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908149T ATE163133T1 (de) 1992-03-13 1993-03-15 Pharmazeutische zusammensetzung mit ortspezifischen verabreichung

Country Status (10)

Country Link
US (1) US5753611A (de)
EP (1) EP0630263B1 (de)
JP (1) JPH07507272A (de)
AT (1) ATE163133T1 (de)
AU (1) AU666541B2 (de)
CA (1) CA2131990A1 (de)
DE (1) DE69316978D1 (de)
NL (1) NL9200481A (de)
NZ (1) NZ251449A (de)
WO (1) WO1993017713A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
DK0863866T3 (da) * 1995-10-06 2001-06-11 Vertex Pharma Butyrat-prodrugs afledt af mælkesyre
DE19724670A1 (de) * 1997-06-11 1998-12-24 Max Planck Gesellschaft Inkorporation von pharmakologisch wirksamen Aminosäureanaloga in Proteine
AU2004229501B2 (en) 2003-04-11 2011-08-18 Medimmune, Llc Recombinant IL-9 antibodies and uses thereof
DE102004057196A1 (de) * 2004-11-26 2006-06-01 Rösner Research GmbH & Co.KG Verfahren zur Herstellung von Albumin-Konjugaten mit Nicht-steroidalen Antirheumatika (NSAR)
US7960336B2 (en) * 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US8563527B2 (en) * 2007-08-20 2013-10-22 Pharmain Corporation Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
EP2274007B1 (de) 2008-03-10 2016-12-14 Cornell University Modulation der durchlässigkeit der blut-hirn-schranke

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900911A (nl) * 1989-04-12 1990-11-01 Duphar Int Res Drug-targeting naar de nier.

Also Published As

Publication number Publication date
NZ251449A (en) 1996-07-26
US5753611A (en) 1998-05-19
AU666541B2 (en) 1996-02-15
DE69316978D1 (de) 1998-03-19
NL9200481A (nl) 1993-10-01
JPH07507272A (ja) 1995-08-10
AU3907493A (en) 1993-10-05
EP0630263A1 (de) 1994-12-28
EP0630263B1 (de) 1998-02-11
CA2131990A1 (en) 1993-09-16
WO1993017713A1 (en) 1993-09-16

Similar Documents

Publication Publication Date Title
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
NO307402B1 (no) Farmasøytiske formuleringer av osteogeniske proteiner
DE69429729D1 (de) Orales verabreichungssystem von desferrioxamin
ES2009346A6 (es) Procedimiento de preparacion de composiciones farmaceuticas que contienen polipeptidos hidroinsolubles.
EP0696208A4 (de) Orale dareichungsform und verfahren
ATE163133T1 (de) Pharmazeutische zusammensetzung mit ortspezifischen verabreichung
KR890006252A (ko) 분말형 폴리펩타이드의 비강내 투여용 조성물 및 투여방법
DE69417868D1 (de) Peptidderivate von alpha-msh und deren anwendung
KR950703999A (ko) 변성된 인슐린-유사 성장인자(modified insulin-like growth factors)
DE3689983D1 (de) Arzneimittel mit langsamer Wirkstofffreisetzung.
KR890003400A (ko) 경비(經鼻)투여용 생리 활성 펩티드 분말 조성물(제제)
DE69129696D1 (de) Polymeres arzneimittelabgabesystem
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
JPS6442433A (en) Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture
ATE104863T1 (de) Pharmazeutische formulierung von plasminogenaktivatorproteinen.
FR2768341B1 (fr) Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
DE69627691D1 (de) Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen
ATE86965T1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
DE3770658D1 (de) Injizierbare arzneiformulierungen von substanzen mit allgemeiner anaesthetischer wirkung.
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
CA2202520A1 (en) Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
ES2058316T3 (es) Procedimiento para la obtencion de un medicamento antitusigeno.
TH22936A (th) สารผสมตามสูตรทางเภสัชกรรม

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties